Cargando…
Safety assessment of the fungal immunomodulatory protein from Ganoderma microsporum (GMI) derived from engineered Pichia pastoris: Genetic toxicology, a 13-week oral gavage toxicity study, and an embryo-fetal developmental toxicity study in Sprague-Dawley rats
The 12.4 kDa fungal immunomodulatory protein from Ganoderma microsporum (GMI) has bioactivity in vitro and in vivo. This study assessed the safety of GMI derived from engineered Pichia pastoris in Sprague-Dawley rats as a dietary supplement and food ingredient by evaluating subchronic toxicity, tera...
Autores principales: | Fu, Hsu-Yuan, Hseu, Ruey-Shyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742912/ https://www.ncbi.nlm.nih.gov/pubmed/36518484 http://dx.doi.org/10.1016/j.toxrep.2022.05.013 |
Ejemplares similares
-
The Protective Role of GMI, an Immunomodulatory Protein From
Ganoderma microsporum, on 5-Fluorouracil-Induced Oral and
Intestinal Mucositis
por: Li, Che-Hsing, et al.
Publicado: (2019) -
CD133 inhibition via autophagic degradation in pemetrexed-resistant lung cancer cells by GMI, a fungal immunomodulatory protein from Ganoderma microsporum
por: Hsin, I-Lun, et al.
Publicado: (2020) -
GMI, an Immunomodulatory Peptide from Ganoderma microsporum, Restrains Periprosthetic Joint Infections via Modulating the Functions of Myeloid-Derived Suppressor Cells and Effector T Cells
por: Peng, Kuo-Ti, et al.
Publicado: (2021) -
Ganoderma microsporum immunomodulatory protein, GMI, promotes C2C12 myoblast differentiation in vitro via upregulation of Tid1 and STAT3 acetylation
por: Teo, Wan-Huai, et al.
Publicado: (2020) -
GMI, a protein from Ganoderma microsporum, induces ACE2 degradation to alleviate infection of SARS-CoV-2 Spike-pseudotyped virus
por: Yeh, Hsin, et al.
Publicado: (2022)